Enrollment in soquelitinib registrational Phase 3 relapsed/refractory peripheral T-cell lymphoma (PTCL) and Phase 2 atopic ...
<?xml encoding="utf-8" ?> Arcutis Biotherapeutics ARQT reported third-quarter financial results on Wednesday. The transcript ...
First patient completed observation period following PBGENE-DMD treatment with no reported safety concerns - - Independent Data Safety Monitoring Board endorses proceeding with dosing additional ...
Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage, small molecule precision medicine company developing potentially ...
When the mid-IR laser is tuned to a wavelength that excites molecular vibrations in the sample, absorption of IR energy ...
Ladies and gentlemen, thank you for standing by. Welcome to Arcutis Biotherapeutics Third Quarter 2026 Earnings Conference ...
King Fahd University of Petroleum and Minerals (KFUPM) is inviting prospective researchers to explore fully funded PhD and ...
The Nasdaq 100 lost some $2 trln of value after the AI trade spooked investors. Whether data-center spending, elections or memory prices sparked the selloff, the wild hype was bound to be tamed. If ...
Watch Yahoo Finance's streaming coverage for real-time market news, analysis, and expert commentary throughout the day to help you make smarter money decisions.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results